Академический Документы
Профессиональный Документы
Культура Документы
Name ID Roll
MISSION- PROVIDE QUALITY HEALTHCARE PRODUCTS AND SERVICES FOR THE BENEFIT OF
HUMANITY IN THE BEST POSSIBLE WAY THROUGH INNOVATION AND DIVERSIFICATION.
VISION- OUR VISION IS TO BECOME A TRUSTED HEALTHCARE COMPANY TO ENSURE BETTER
HEALTH FOR EVERYONE, EVERYWHERE
VALUE CHAIN ANALYSIS
WEAKNESSES:
ABSENCE OF INTERNATIONAL STANDARD QUALITY CONTROL AND TESTING LABORATORY
LITTLE RESEARCH AND DEVELOPMENT ON NEW MOLECULE DEVELOPMENT ETC.
SWOT ANALYSIS (CONTINUED)
OPPORTUNITIES:
LARGE POTENTIAL FOR EXPORT MARKET EXPANSION
SCOPE FOR PRODUCT DIVERSIFICATION
SCOPE TO TAKE ADVANTAGE OF PARALLEL IMPORTS.
RESEARCH AND DEVELOPMENT ACTIVITIES MAY BE INITIATED WITH EXTERNAL SUPPORT.
THREATS:
CHEAPER MEDICINE FROM CHINA AND INDIA.
COUNTRIES SUPPLYING PRODUCTS THROUGH UNAUTHORIZED CHANNELS.
INCREASE OF PRICE OF RAW MATERIALS.
SUMMARIZING THE SWOT
AVAILING OPPORTUNITIES USING STRENGTH:
USING PARALLEL IMPORTS TO AVAIL THE ADVANTAGE OF LARGE DOMESTIC MARKET.
ENTER NEW MARKETS TO AVAIL THE ADVANTAGE OF BEING VIEWED AS A CHEAP BUT QUALITY MEDICINE
PROVIDER.
DIVERSIFY TO HERBAL MEDICINES AND MEDICINES FOR ANIMALS TO USE THE EXISTING RESOURCES MORE
EFFICIENTLY.
WHY EXPORTING?
MARKET SEEKING PURPOSE- A BIGGER MARKET WILL ALLOW THE COMPANY TO PRODUCE MORE PRODUCTS, THUS
IT WILL LET THE COMPANY TO AVAIL THE ADVANTAGES OF ECONOMIES OF SCALE, THUS COMPETING BETTER WITH
CHINA AND INDIA.
WHAT FACTORS DID THEY CONSIDER WHILE
INVESTING IN THE FOREIGN MARKET?
EXTERNAL FACTORS
ACQUISITION
THIS FIRM ACQUIRE, THE FINANCIAL PUBLIC RELATIONS AND MARKETING GROUP, IS IN TALKS
OVER AN ALL-SHARE MERGER WITH RIVAL HUNTSWORTH.
PROBLEM
INTEGRATING FOREIGN SUBSIDIARIES INTO THE PARENTS SYSTEM.
STRATEGY OF THE FIRM
WHAT HAD BEEN THE MAJOR AND OTHER IMPORTANT ISSUES THEY
FACED DURING THE INTERNATIONALIZATION PROCESS?
FROM THE VERY BEGINNING, INCEPTA HAS FOCUSED ON LAUNCHING NEWER AND
INNOVATIVE PRODUCTS. HIGH INVESTMENT IN R&D AND ADVANCED TECHNOLOGY HAS
ALLOWED THE COMPANY TO LAUNCH 429 GENERICS WITH 783 PRESENTATIONS, 158 OF
WHICH WERE INTRODUCED FIRST TIME IN BANGLADESH.
ENDING REMARKS FROM OUR
PRESENTATION
CONCLUSION
INCEPTA STRONGLY BELIEVES THAT COMMITMENT TOWARDS PEOPLE AND THE SOCIETY AS A
WHOLE POSITIVELY CONTRIBUTES TOWARDS ITS BUSINESS OBJECTIVE.
INCEPTA ADOPTS DIFFERENT STRATEGIES, WHICH CREATE A SUSTAINABLE ADVANTAGE FOR THE
COMPANY.
IT IS THE FIRST BANGLADESHI PHARMACEUTICAL COMPANY TO IMPLEMENT SAP TO MANAGE
RESOURCES THROUGHOUT THE COMPANY OPERATION.
THIS WORLD CLASS RESOURCE MANAGEMENT SYSTEM ALLOWS THE COMPANY TO BECOME MORE
EFFICIENT AND EFFECTIVE IN ITS DAY TO DAY OPERATION.
INCEPTA IS TAKING SPECIAL EFFORTS TO ENSURE PRESENCE IN THE REST OF THE GLOBE.